Troglitazone and small low-density lipoprotein in type 2 diabetes

被引：23

作者：

Hirano, T ^{[1
]}

Yoshino, G

Kazumi, T

机构：

[1] Showa Univ, Sch Med, Tokyo 142, Japan

[2] Toho Univ, Sch Med, Tokyo, Japan

[3] Ilyogo Rehabil Ctr Hosp, Tokyo, Japan

来源：

ANNALS OF INTERNAL MEDICINE | 1998年 / 129卷 / 02期

关键词：

D O I：

10.7326/0003-4819-129-2-199807150-00030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：162 / 163

页数：2

相关论文

共 5 条

[1] CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS
FUJIWARA, T
YOSHIOKA, S
YOSHIOKA, T
USHIYAMA, I
HORIKOSHI, H
[J]. DIABETES, 1988, 37 (11) : 1549 - 1558
[2] EFFECT OF NEW ORAL ANTIDIABETIC AGENT CS-045 ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN PATIENTS WITH NIDDM
IWAMOTO, Y
KUZUYA, T
MATSUDA, A
AWATA, T
KUMAKURA, S
INOOKA, G
SHIRAISHI, I
[J]. DIABETES CARE, 1991, 14 (11) : 1083 - 1086
[3] KRAUSS RM, 1982, J LIPID RES, V23, P97
[4] INSULIN-RESISTANCE AND HYPERINSULINEMIA IN INDIVIDUALS WITH SMALL, DENSE, LOW-DENSITY-LIPOPROTEIN PARTICLES
REAVEN, GM
CHEN, YDI
JEPPESEN, J
MAHEUX, P
KRAUSS, RM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) : 141 - 146
[5] LDL SUBCLASS PHENOTYPES AND THE INSULIN-RESISTANCE SYNDROME IN WOMEN
SELBY, JV
AUSTIN, MA
NEWMAN, B
ZHANG, D
QUESENBERRY, CP
MAYER, EJ
KRAUSS, RM
[J]. CIRCULATION, 1993, 88 (02) : 381 - 387